Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
posted on
Nov 14, 2022 06:49PM
NBB
In my experience with M&A, which I have had first hand quite a bit for what it's worth, companies don't typically buy another company to take it out.
Why? Because that company must have value that they are worried about. So instead of buying out to retire it...they buy it out to acquire. And grow it. That's how it's done
10BagR